Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure patients

BMC Cardiovascular Disorders

Volumn 9, Issue , 2009, Pages 41-

  Mekki, Khedidja ^a   Prost, Josiane ^b   Remaoun, Mustapha ^c   Belleville, Jacques ^b   Bouchenak, Malika ^a  

^a UNIVERSITY OF ORAN   (Algeria)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Centre Hospitalo Universitaire de Sidi Bel Abbès   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; LIPOLYSIS; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; TREATMENT DURATION;

ADULT; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; LIPASE; LIPOLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 70349869023     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-9-41     Document Type: Article

References (26)

1. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. The Metabolic and Molecular Bases of Inherited Disease 2001, 2789-816. New York, NY: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B.
2. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008, 108:99-105.
3. Kogan A, Medalion B, Kornowski R, Raanani E, Sharoni E, Stamler A, Sahar G, Snir E, Porat E. Cardiac surgery in patients on chronic hemodialysis: short and long-term survival. Thorac Cardiovasc Surg 2008, 56:123-7. 10.1055/s-2007-989396, 18365968.
4. Okechukwu CH, Lopes AA, Stack AG, Feng S, Wolfe RA, Port FK. Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors. Am J Kid Dis 2002, 39:533-8. 10.1053/ajkd.2002.31403, 11877572.
5. Chan DT, Irish AB, Dogra CK, Watts GF. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis 2008, 196:823-834. 10.1016/j.atherosclerosis.2007.01.023, 17343861.
6. Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment. American Journal of Nephrology 2008, 28:958-973. 10.1159/000144024, 18612199.
7. Prinsen BH, De Sain-van der Velden MG, De Koning EJ, Koomans HA, Berger R, Rabelink TJ. Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms. Kidney International 2003, 63:121-124.
8. Cullen P. Triglycerides: Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000, 86(9):943-949. 10.1016/S0002-9149(00)01127-9, 11053704.
9. Senti M, Romero R, Pedro-Botet J, Pelegri A, Noguès X, Rubiès-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis chronic renal failure. Kidney Int 1992, 41:1394-9. 10.1038/ki.1992.204, 1614054.
10. Elisaf MS, Bairaktari HT, Tziallas CS, Germanos NK, Siamopoulos KC. Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Dial Trans 1995, 24:642-60.
11. Ponticelli C, Barbi G, Cataluppi A, Donati C, Annoni G, Brancacci D. Lipid abnormalities in maintenance dialysis patients and renal transplant patients. Kidney Int 1978, 13:572-8.
12. Ifudu O, Brezsnyak WF, Reydel C, McClendon E, Surgrue T, DiRienzo R, Avram MM, Friedman EA. Pathobiology and functional status of long-term haemodialysis patients. Am J Nephrol 1995, 15:379-5. 10.1159/000168870, 7503136.
13. Haas LB, Wahl PW, Sherrard DJ. A longitudinal study of lipid abnormalities in renal failure. Nephron 1983, 33:145-51. 10.1159/000182929, 6835462.
14. Sobh MA, Shamaa SA, El-Gayar AM, El Sharabacy MM. Hyperlipidemia in uremic patients under chronic hemodialysis. Correlation with serum lipoprotein lipase and insulin levels. Inter Urol Nephro 1989, 21:667-74.
15. Paragh G, Balogh Z, Matyus J, Kárpáti I, Ujhelyi L, Kakuk G, Leövey A. Lipid abnormalities in uraemic patients on chronic hemodialysis. Acta Medica Hungarica 1993, 49:207-17.
16. Mekki K, Bouchenak M, Lamri M, Remaoun M, Belleville J. Changes in plasma lecithin: cholesterol acyltransferase activity, HDL2, HDL3 amounts and compositions in patients with chronic renal failure after different times of hemodialysis. Atherosclerosis 2002, 162:409-17. 10.1016/S0021-9150(01)00728-6, 11996961.
17. Mekki K, Prost J, Bouchenak M, Remaoun M, Belleville J. Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis. Atherosclerosis 2003, 169:269-77. 10.1016/S0021-9150(03)00011-X, 12921978.
18. Nilsson-Ehle P, Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 1977, 3:194-209.
19. Nilsson-Ehle P, Schotz MC. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 1976, 17:536-41.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-53. 10.1172/JCI103182, 438705, 13252080.
21. Redgrave TG, Roberts DC, West CE. Separation of plasma lipoprotein gradient ultracentrifugation. Anal Biochem 1987, 65:42-9. 10.1016/0003-2697(75)90488-1.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RI. Protein measurement with the folin reagent. J Biol Chem 1951, 193:265-75.
23. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966, 1:45-52.
24. Mekki K, Prost J, Bouchenak M, Remaoun M, Belleville J. Consommation alimentaire et durée d'hémodialyse chez l'insuffisant rénal chronique: corrélation aux paramètres nutritionnels. Cah Nutr Diét 2004, 39(3):211-216.
25. Tsutsumi K. Lipoprotein lipase and atherosclerosis. Curr Vasc Pharmacol 2003, 1:11-17. 10.2174/1570161033386673, 15320848.
26. Mekki K, Bouchenak M, Remaoun M, Belleville J. Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study. Med Sci Monit 2004, 10(8):CR439-CR446.